460 related articles for article (PubMed ID: 19671787)
1. Intravenous immunoglobulins in systemic lupus erythematosus: from the bench to the bedside.
Zandman-Goddard G; Blank M; Shoenfeld Y
Lupus; 2009 Sep; 18(10):884-8. PubMed ID: 19671787
[TBL] [Abstract][Full Text] [Related]
2. High-dose intravenous immunoglobulins: an option in the treatment of systemic lupus erythematosus.
Toubi E; Kessel A; Shoenfeld Y
Hum Immunol; 2005 Apr; 66(4):395-402. PubMed ID: 15866703
[TBL] [Abstract][Full Text] [Related]
3. [Long-term treatment with i.v. immunoglobulin in the therapy of systemic lupus erythematosus].
Francioni C; Fioravanti A; Gelli R; Megale F; Marcolongo R
Recenti Prog Med; 1993 Oct; 84(10):679-86. PubMed ID: 8235034
[TBL] [Abstract][Full Text] [Related]
4. Intravenous immune globulin therapy of lupus nephritis: use of pathogenic anti-DNA-reactive IgG.
Silvestris F; D'Amore O; Cafforio P; Savino L; Dammacco F
Clin Exp Immunol; 1996 May; 104 Suppl 1():91-7. PubMed ID: 8625551
[TBL] [Abstract][Full Text] [Related]
5. Treatment of systemic lupus erythematosus by prolonged administration of high dose intravenous immunoglobulin: report of 2 cases.
Winder A; Molad Y; Ostfeld I; Kenet G; Pinkhas J; Sidi Y
J Rheumatol; 1993 Mar; 20(3):495-8. PubMed ID: 8478856
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin for immunomodulation of systemic lupus erythematosus.
Sherer Y; Shoenfeld Y
Autoimmun Rev; 2006 Feb; 5(2):153-5. PubMed ID: 16431350
[TBL] [Abstract][Full Text] [Related]
7. Intravenous immunoglobulin abrogates dendritic cell differentiation induced by interferon-alpha present in serum from patients with systemic lupus erythematosus.
Bayry J; Lacroix-Desmazes S; Delignat S; Mouthon L; Weill B; Kazatchkine MD; Kaveri SV
Arthritis Rheum; 2003 Dec; 48(12):3497-502. PubMed ID: 14674000
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of specific IVIG anti-idiotypic antibodies in antiphospholipid syndrome (APS): trophoblast invasiveness and APS animal model.
Blank M; Anafi L; Zandman-Goddard G; Krause I; Goldman S; Shalev E; Cervera R; Font J; Fridkin M; Thiesen HJ; Shoenfeld Y
Int Immunol; 2007 Jul; 19(7):857-65. PubMed ID: 17576752
[TBL] [Abstract][Full Text] [Related]
9. Low dose intravenous immunoglobulin in systemic lupus erythematosus: analysis of 62 cases.
Sherer Y; Kuechler S; Jose Scali J; Rovensky J; Levy Y; Zandman-Goddard G; Shoenfeld Y
Isr Med Assoc J; 2008 Jan; 10(1):55-7. PubMed ID: 18300575
[TBL] [Abstract][Full Text] [Related]
10. Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion.
Perricone R; De Carolis C; Kröegler B; Greco E; Giacomelli R; Cipriani P; Fontana L; Perricone C
Rheumatology (Oxford); 2008 May; 47(5):646-51. PubMed ID: 18346976
[TBL] [Abstract][Full Text] [Related]
11. High dose intravenous immunoglobulins in systemic lupus erythematosus: clinical and serological results of a pilot study.
Schroeder JO; Zeuner RA; Euler HH; Löffler H
J Rheumatol; 1996 Jan; 23(1):71-5. PubMed ID: 8838511
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of systemic lupus erythematosus with intravenous human immunoglobulins. Preliminary study].
Migliaresi S; Gallo M; Tirri G
Clin Ter; 1992 Sep; 141(9 Pt 2):83-4. PubMed ID: 1468203
[TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulin therapy and systemic lupus erythematosus.
Zandman-Goddard G; Levy Y; Shoenfeld Y
Clin Rev Allergy Immunol; 2005 Dec; 29(3):219-28. PubMed ID: 16391397
[TBL] [Abstract][Full Text] [Related]
14. IVIg therapy in autoimmunity and related disorders: our experience with a large cohort of patients.
Shoenfeld Y; Katz U
Autoimmunity; 2005 Mar; 38(2):123-37. PubMed ID: 16040333
[TBL] [Abstract][Full Text] [Related]
15. Toward molecular targeting with specific intravenous immunoglobulin preparation.
Blank M; Nur I; Toub O; Maor A; Shoenfeld Y
Clin Rev Allergy Immunol; 2005 Dec; 29(3):213-7. PubMed ID: 16391396
[TBL] [Abstract][Full Text] [Related]
16. Chronic inflammatory demyelinating polyneuropathy in patients with systemic lupus erythematosus: prognosis and outcome.
Vina ER; Fang AJ; Wallace DJ; Weisman MH
Semin Arthritis Rheum; 2005 Dec; 35(3):175-84. PubMed ID: 16325658
[TBL] [Abstract][Full Text] [Related]
17. [Intravenous administration of immunoglobulins in systemic lupus erythematosus: review of the literature and initial clinical experiences].
Pirner K; Rubbert A; Burmester GR; Kalden JR; Manger B
Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():131-5; discussion 136. PubMed ID: 8499742
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment with intravenous immunoglobulins in a patient affected by dermatomyositis/systemic lupus erythematosus overlap syndrome and tuberculosis.
Luzi G; Diamanti AP; Germano V; Laganà B; Di Rosa R; Salemi S; Stoppacciaro A; D'Amelio R
Clin Immunol; 2007 Nov; 125(2):127-30. PubMed ID: 17720626
[TBL] [Abstract][Full Text] [Related]
19. [Intravenous immunoglobulin (IVIG)].
Hara M
Nihon Rinsho; 2009 Mar; 67(3):599-605. PubMed ID: 19280939
[TBL] [Abstract][Full Text] [Related]
20. [High dose intravenous immunoglobulins in treating systemic lupus erythematosus-associated thrombocytopenia].
Zhang X; Dong Y; Tang F; Zhang F; Li H
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Feb; 22(1):82-4. PubMed ID: 12903501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
